-
1
-
-
34848922529
-
-
See the European Generic Medicines Association website at http://www.egagenerics.com/gen-evergrn.htm.
-
See the European Generic Medicines Association website at http://www.egagenerics.com/gen-evergrn.htm.
-
-
-
-
2
-
-
34848857437
-
-
Changing patterns of Pharmaceutical Innovation, A research report by the National Institute for Health Care Management Research and Educational Foundation, May 2002
-
Changing patterns of Pharmaceutical Innovation - A research report by the National Institute for Health Care Management Research and Educational Foundation - May 2002.
-
-
-
-
3
-
-
34848870977
-
-
The importance of incremental innovation for development, Innovation and Public Health by the International Chamber of Commerce's Commission on Intellectual Property
-
The importance of incremental innovation for development. A submission to the World Health Organisation's Commission on Intellectual Property Rights, Innovation and Public Health by the International Chamber of Commerce's Commission on Intellectual Property, 2005.
-
(2005)
A submission to the World Health Organisation's Commission on Intellectual Property Rights
-
-
-
4
-
-
34848858628
-
-
Indeed, in 2002 President Bush referred to '...patents based on minor features such as the colour of the pill bottle or a specific combination of ingredients unrelated to the drug's effectiveness...' in announcing reforms aimed at combating alleged abuses that have kept generics off the US market.
-
Indeed, in 2002 President Bush referred to '...patents based on minor features such as the colour of the pill bottle or a specific combination of ingredients unrelated to the drug's effectiveness...' in announcing reforms aimed at combating alleged abuses that have kept generics off the US market.
-
-
-
-
5
-
-
34848844462
-
-
To promote innovation: The proper balance of competition and patent law and policy. Federal Trade Commission Report 2003, http://www.ftc.gov.
-
To promote innovation: The proper balance of competition and patent law and policy. Federal Trade Commission Report 2003, http://www.ftc.gov.
-
-
-
-
6
-
-
34848908798
-
-
Synthon B V v Smith Kline Beecham, PLC 14th February, 2003 Ch D (Patents Ct) gacob J) LTL 25/2/2003.
-
Synthon B V v Smith Kline Beecham, PLC 14th February, 2003 Ch D (Patents Ct) gacob J) LTL 25/2/2003.
-
-
-
-
7
-
-
7644244953
-
-
Ownership of Knowledge - the role of patents in pharmaceutical R&D. Correa. Bulletin of the World Health Organisation October 2004, 82(10), 784-790.
-
Ownership of Knowledge - the role of patents in pharmaceutical R&D. Correa. Bulletin of the World Health Organisation October 2004, 82(10), 784-790.
-
-
-
-
8
-
-
34848817801
-
-
Drafts of a patent reform bill that provides for the introduction of a post-grant opposition procedure and a switch from the present 'first to invent' patent system to one founded on the 'first inventor to file' are presently under review by the US legislature. If enacted in a form similar to the discussion draft this would go a long way towards harmonising patent law between the US and Europe
-
Drafts of a patent reform bill that provides for the introduction of a post-grant opposition procedure and a switch from the present 'first to invent' patent system to one founded on the 'first inventor to file' are presently under review by the US legislature. If enacted in a form similar to the discussion draft this would go a long way towards harmonising patent law between the US and Europe.
-
-
-
-
9
-
-
34848900884
-
-
Smith Kline Beecham and others v Apotex Europe and Others 2002 EWHC 2556 (Pat). SmithKline Beecham v Generics UK 2002, IPD January 2005.
-
Smith Kline Beecham and others v Apotex Europe and Others 2002 EWHC 2556 (Pat). SmithKline Beecham v Generics UK 2002, IPD January 2005.
-
-
-
-
10
-
-
34848919302
-
-
Mayne Pharma and another v Pharmacia Italia 2005. LTL 17/2/2005: 2005 28(3) IPD1.
-
Mayne Pharma and another v Pharmacia Italia 2005. LTL 17/2/2005: 2005 28(3) IPD1.
-
-
-
|
